Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 10, 2021 21:00 ET | Source: DelveInsight Business Research LLP

Bronchiolitis Obliterans Syndrome Pipeline Progresses With Novel, Innovative Therapies Expected to Embrace the Space in the Next Decade

Los Angeles, USA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Bronchiolitis Obliterans Syndrome Pipeline Progresses With Novel, Innovative Therapies Expected to Embrace the Space in the Next Decade With...
August 09, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Peanut Allergy Pipeline Insight Report Proffers Clinical Trials Updates, Including Detailed Profiles of Emerging Drugs Along With Companies

Los Angeles, USA, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Peanut Allergy Pipeline Insight Report Proffers Clinical Trials Updates, Including Detailed Profiles of Emerging Drugs Along With Companies ...
August 05, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Novel Drugs are Being Investigated for Gaucher's Disease Treatment: A Clinical Trial Analysis Review by DelveInsight

Los Angeles, USA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Novel Drugs are Being Investigated for Gaucher's Disease Treatment: A Clinical Trial Analysis Review by DelveInsight Enzyme replacement therapy...
August 04, 2021 21:00 ET | Source: DelveInsight Business Research LLP

A Robust Neuromyelitis Optica Spectrum Disorder Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of Clinical Development Expected to Enter the Market by the Next Decade

Los Angeles, USA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A Robust Neuromyelitis Optica Spectrum Disorder Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of Clinical...
August 03, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Promising Treatment for Cutaneous T-cell Lymphoma Enters Clinical Trials

Los Angeles, USA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Promising Treatment for Cutaneous T-cell Lymphoma Enters Clinical Trials Around 25+ key companies are developing Cutaneous T-Cell Lymphoma...
August 02, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Respiratory Syncytial Virus Infection Pipeline: Insights into Clinical Trial Landscape, Key Pharma Players, Emerging Therapies with Novel MoAs, and Dynamics Shaping the Pipeline Landscape | DelveInsight

Los Angeles, USA, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Respiratory Syncytial Virus Infection Pipeline: Insights into Clinical Trial Landscape, Key Pharma Players, Emerging Therapies with Novel MoAs,...
July 27, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Recent Advances in the Bipolar Depression Treatment | Bipolar Depression Clinical Trials Analysis Review

Los Angeles, USA, July 27, 2021 (GLOBE NEWSWIRE) -- Recent Advances in the Bipolar Depression Treatment | Bipolar Depression Clinical Trials Analysis Review Around 10+ key companies are developing...
July 26, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape

Los Angeles, July 26, 2021 (GLOBE NEWSWIRE) -- Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape With...
July 22, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Recent Clinical Trials Analysis on Myasthenia Gravis Treatment

Los Angeles, USA, July 22, 2021 (GLOBE NEWSWIRE) -- Recent Clinical Trials Analysis on Myasthenia Gravis Treatment Around 15+ key companies are developing the Myasthenia Gravis therapies. Argenx...
July 20, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario.

Los Angeles, USA, July 20, 2021 (GLOBE NEWSWIRE) -- Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario. The growing Type 2 Diabetes prevalence has increased the demand for...